A Stratification trial to determine key immunological factors predicting Tofacitinib efficacy and drug free remission in Psoriatic Arthritis (PsA). TOFA-PREDICT

Trial Profile

A Stratification trial to determine key immunological factors predicting Tofacitinib efficacy and drug free remission in Psoriatic Arthritis (PsA). TOFA-PREDICT

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Apr 2018

At a glance

  • Drugs Tofacitinib (Primary) ; Etanercept; Methotrexate; Methotrexate
  • Indications Psoriatic arthritis
  • Focus Therapeutic Use
  • Acronyms TOFA-PREDICT
  • Most Recent Events

    • 17 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top